pillbase.ru

VIMIZIM

Active substance: elosulfase alfa

INJECTION, SOLUTION, CONCENTRATE · ELOSULFASE ALFA 5 mg/5mL

United StatesActive

Marketing holder: BioMarin Pharmaceutical Inc.

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 2
  • Вимизайм
    концентрат для приготовления раствора для инфузий, 1 мг/мл, 5 мл (original in Russian, GRLS)
    ЛП-005202
    БиоМарин Интернэшнл Лимитед
  • Вимизайм®
    концентрат для приготовления раствора для инфузий, 1 мг/мл, 5 мл (original in Russian, GRLS)
    ЛП-№(001669)-(РГ-RU)
    БиоМарин Интернэшнл Лимитед
EU 1
  • Vimizim
    recombinant human n-acetylgalactosamine-6-sulfatase
    EMEA/H/C/002779
    BioMarin International Limited
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-417d-7c65-9783-1192f7bdc8c8,01a120c5-cb01-7e52-83c5-5c36cb35e93f;count=2 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208e-bc29-786b-ab3e-a2afa966d134;count=1 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
68135-100
Registration status
Active
Dispensing
Prescription only
Route
INTRAVENOUS
Sources
  • product · openFDA NDC · 68135-100 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 68135-100 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 68135-100 · Verified 2026-10-09 · open in source